Joel Greenblatt's ADPT Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 140,756 shares of Adaptive Biotechnologies Corporation (ADPT) worth $2.29 M, representing 0.01% of the portfolio. First purchased in 2022-Q2, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in ADPT, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 61,194 shares. Largest reduction occurred in Q2 2023, reducing 30,210 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Adaptive Biotechnologies Corporation (ADPT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Adaptive Biotechnologies Corporation (ADPT) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +13,692 | Add 10.78% | 140,756 | $16.24 |
| Q3 2025 | +55,177 | Add 76.76% | 127,064 | $14.96 |
| Q2 2025 | +61,194 | Add 572.28% | 71,887 | $11.65 |
| Q1 2025 | +10,693 | New Buy | 10,693 | $7.43 |
| Q3 2023 | -16,073 | Sold Out | 0 | $0.00 |
| Q2 2023 | -30,210 | Reduce 65.27% | 16,073 | $6.71 |
| Q1 2023 | +14,616 | Add 46.16% | 46,283 | $8.83 |
| Q4 2022 | -19,816 | Reduce 38.49% | 31,667 | $7.64 |
| Q3 2022 | -723 | Reduce 1.38% | 51,483 | $7.13 |
| Q2 2022 | +52,206 | New Buy | 52,206 | $8.08 |
Joel Greenblatt's Adaptive Biotechnologies Corporation Investment FAQs
Joel Greenblatt first purchased Adaptive Biotechnologies Corporation (ADPT) in Q2 2022, acquiring 52,206 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Adaptive Biotechnologies Corporation (ADPT) for 10 quarters since Q2 2022.
Joel Greenblatt's largest addition to Adaptive Biotechnologies Corporation (ADPT) was in Q2 2025, adding 71,887 shares worth $837,484.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 140,756 shares of Adaptive Biotechnologies Corporation (ADPT), valued at approximately $2.29 M.
As of the Q4 2025 filing, Adaptive Biotechnologies Corporation (ADPT) represents approximately 0.01% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Adaptive Biotechnologies Corporation (ADPT) was 140,756 shares, as reported at the end of Q4 2025.